VENTUS THERAPEUTICS
Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system.
VENTUS THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.ventustx.com
Total Employee:
51+
Status:
Active
Contact:
514-397-9517
Email Addresses:
[email protected]
Total Funding:
370.15 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics SSL By Default
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Sionna Therapeutics
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Ventus Therapeutics
Novo Nordisk
Novo Nordisk investment in Corporate Round - Ventus Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series C - Ventus Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Ventus Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Ventus Therapeutics
Versant Ventures
Versant Ventures investment in Series C - Ventus Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Ventus Therapeutics
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series C - Ventus Therapeutics
Casdin Capital
Casdin Capital investment in Series C - Ventus Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series C - Ventus Therapeutics
Key Employee Changes
Official Site Inspections
http://www.ventustx.com Semrush global rank: 3.14 M Semrush visits lastest month: 4.81 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ventus Therapeutics"
The Power of Resolution - Ventus Therapeutics
We are a clinical-stage biopharmaceutical company leveraging our machine learning-enabled ReSOLVEâ„¢ platform to advance a pipeline of novel medicines in immunology, inflammation, …See details»
Ventus Therapeutics Significantly Expands its Presence …
Jul 16, 2024 · The new facility serves as Ventus’ Montreal-based offices and laboratories for its drug discovery and development organization, including its medicinal chemistry, computational chemistry, DMPK, and disease biology …See details»
Overview - Ventus Therapeutics
Ventus Therapeutics is a clinical-stage biopharmaceutical company deploying leading-edge structural biology and unique machine learning and computational chemistry tools to develop a robust pipeline of novel medicines in …See details»
Ventus Therapeutics | Creating Exceptional Medicines with …
We are advancing a pipeline of novel medicines to potentially treat a wide variety of indications, including autoimmune and inflammatory diseases, dermatological diseases, and neurological …See details»
Ventus Therapeutics - LinkedIn
At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but difficult-to-drug targets. Others are building towards a future...See details»
Ventus Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 514-397-9517 Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat …See details»
Ventus Therapeutics - LinkedIn
At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but difficult-to-drug targets. Others are building towards a future...See details»
Overview | Ventus Therapeutics
Ventus Therapeutics deploys leading-edge structural biology and unique computational chemistry tools to discover novel small molecule medicines for challenging targets in immunology, inflammation, and neurology. Others are …See details»
Ventus Therapeutics - Overview, News & Similar companies
Apr 17, 2024 · View Ventus Therapeutics (www.ventustx.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
Ventus Therapeutics Company Profile 2024: Valuation, Funding ...
Developer of structural immunology-based therapeutics designed to navigate elusive targets. The company focuses on developing small-molecule medicines to target proteins in the …See details»
Overview - Ventus Therapeutics
We are looking for candidates who are capable of designing intelligent and creative solutions to complex problems, have the courage and resilience to work on elusive drug targets, and are ready to build a world-class organization from …See details»
Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in ...
Jan 3, 2024 · For more information about Ventus’ pipeline and ReSOLVE TM platform, visit www.VentusTx.com. About cGAS cGAS is an intracellular pattern recognition receptor that is …See details»
Ventus Therapeutics | Portfolio - Versant Ventures
Ventus is discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. © 2024 …See details»
Ventus Therapeutics Opens New Facility in Waltham, MA as First …
Sep 6, 2022 · This new facility augments Ventus’ existing 10,000-square-foot facility in Montreal, which houses Ventus’ drug discovery and development organization, including its medicinal …See details»
Ventus Therapeutics Opens New Facility in Waltham, MA as First …
Sep 6, 2022 · This new facility augments Ventus’ existing 10,000-square-foot facility in Montreal, which houses Ventus’ drug discovery and development organization, including its medicinal …See details»
Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in ...
Jan 3, 2024 · Ventus Therapeutics is a clinical-stage biopharmaceutical company deploying leading-edge structural biology and computational chemistry tools to create novel small …See details»
Ventus Therapeutics Significantly Expands its Presence in Montreal ...
Jul 16, 2024 · The new facility serves as Ventus’ Montreal-based offices and laboratories for its drug discovery and development organization, including its medicinal chemistry, computational …See details»
Pipeline | Ventus Therapeutics
Our ReSOLVEâ„¢ platform enables a highly differentiated pipeline of small molecule therapeutics for highly validated innate immunity targets. Our lead programs target the inflammasome and …See details»
Pipeline - Ventus Therapeutics
Our ReSOLVEâ„¢ platform enables a highly differentiated pipeline of small molecule therapeutics for highly validated innate immunity targets. Our lead programs target the inflammasome and …See details»
What you need to know about extreme child poverty in Armenia
1 day ago · The trap of extreme poverty, as I already said, repeats itself from generation to generation. When a child is born into extreme poverty, the family, from young to old, is already …See details»